Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

B Lymphocytes in the Adipose Tissue Microenvironment: Multifaceted Roles in Inflammation and Metabolic Dysfunction.

Zouali M.

Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in Immunology (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Immunology (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42504435
DOI
10.1111/imm.70178

Abstract (original English)

Adipose tissue (AT) is now recognised as a dynamic immunometabolic organ in which coordinated interactions between adipocytes, stromal cells, vascular elements, and resident immune populations are essential for maintaining metabolic homeostasis and endocrine function. Beyond its classical role in energy storage, AT actively regulates local and systemic immune responses through the production of adipokines, cytokines, chemokines, and lipid mediators. Among adipose-resident immune cells, B lymphocytes have emerged as multifaceted regulators of tissue inflammation, remodelling, and metabolic function. Distinct B cell subsets populate adipose depots and exert diverse activities, including antibody production, cytokine secretion, antigen presentation, and modulation of innate and adaptive immune responses. In obesity, aging, and chronic inflammatory conditions, AT undergoes profound immunological remodelling characterised by altered adipokine signalling, inflammasome activation, recruitment of inflammatory immune cells, and production of pathogenic autoantibodies. Conventional B-2 cells, double-negative B cells, and T-bet + age-associated B cells generally promote inflammatory responses and insulin resistance through secretion of pro-inflammatory cytokines and IgG autoantibodies, whereas regulatory B cells and innate-like B-1 cells exert protective effects through IL-10 production a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research